Insider Transactions Reported by 17 Insiders of Jounce Therapeutics, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 10 Mar 2025

Jounce Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Concentra Biosciences, LLC 10%+ Owner $67,298,795 03 May 2023
Third Rock Ventures II, L.P. 10%+ Owner $10,631,227 15 Sep 2021
Third Rock Ventures III, L.P. 10%+ Owner $2,650,380 12 Nov 2021
Hugh M. Cole Chief Operating Officer $203,652 09 Jan 2023
Elizabeth Trehu Chief Medical Officer $191,321 09 Jan 2023
Cary Pfeffer Director $93,366 12 Nov 2021
Kevin Tang Director, 10%+ Owner $18,500 03 May 2023
RICHARD /CA/ MURRAY Director $2 03 May 2023
Jigar Raythatha Director 03 May 2023
Barbara Gayle Duncan Director 03 May 2023
Kimberlee C. Drapkin President, CFO and Treasurer 03 May 2023
PERRY A. KARSEN Director 03 May 2023
Robert Iannone Director 03 May 2023
Robert Kamen Director 03 May 2023
Luis Diaz Director 03 May 2023
Luisa Salter-Cid Director 03 May 2023
John Duncan Higgons Director 24 Jun 2022

Recent Insider Transactions by Companies or Individuals for Jounce Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.